The Impact of <i>JAK1</i> Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial CancerErica V. Carballo, Courtney A. Penn, Christina Maxey et al.|Clinical Cancer Research|2025Cited by 2
The impact of JAK1 mutations and MHC-I expression on response to immune checkpoint inhibition in endometrial cancerErica Carballo, Courtney A. Penn, Paula I. González-Ericsson et al.|Gynecologic Oncology|2025Cited by 0
Ovarian cancer proteomic biomarkers for pembrolizumab responseKatherine Kleinberg, Courtney A. Penn, Erica V. Carballo et al.|Gynecologic Oncology Reports|2025Cited by 0
Supplementary Data1 from The Impact of <i>JAK1</i> Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial CancerErica V. Carballo, Courtney A. Penn, Paula I. González-Ericsson et al.|Unknown|2025Cited by 0